» Articles » PMID: 37779871

Traditional Chinese Medicine As a Novel Therapy for Colorectal Cancer by Modulating Intestinal Flora

Overview
Journal J Cancer
Specialty Oncology
Date 2023 Oct 2
PMID 37779871
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer is a common clinical malignant tumor of the digestive tract, and intestinal flora has played an important role in the development of colorectal cancer. Bifidobacteria, as one of the main dominant florae in intestinal tract, can inhibit the occurrence and development of colorectal cancer through various mechanisms. Recent studies have shown that traditional Chinese medicine can regulate the abundance of bifidobacteria in intestinal tract and exhibit anti-tumor effects on colorectal cancer. Detailed investigations have revealed that the mechanisms of bifidobacteria in the treatment of colorectal cancer involve three aspects: the production of short-chain fatty acids, the regulation of the body's immunity, and the regulation of cell apoptosis and differentiation. In this review, we provide an updated summary of recent advances in our understanding of the mechanisms by which traditional Chinese medicine regulate intestinal flora to inhibit colorectal cancer development and metastasis.

Citing Articles

Chinese Medicine in Colorectal Cancer Treatment: From Potential Targets and Mechanisms to Clinical Application.

Guo K, Wang Z, Su X Chin J Integr Med. 2024; .

PMID: 39331211 DOI: 10.1007/s11655-024-4115-8.

References
1.
Che Q, Luo T, Shi J, He Y, Xu D . Mechanisms by Which Traditional Chinese Medicines Influence the Intestinal Flora and Intestinal Barrier. Front Cell Infect Microbiol. 2022; 12:863779. PMC: 9097517. DOI: 10.3389/fcimb.2022.863779. View

2.
Li X, Wu D, Niu J, Sun Y, Wang Q, Yang B . Intestinal Flora: A Pivotal Role in Investigation of Traditional Chinese Medicine. Am J Chin Med. 2021; 49(2):237-268. DOI: 10.1142/S0192415X21500130. View

3.
Funes S, Rios M, Escobar-Vera J, Kalergis A . Implications of macrophage polarization in autoimmunity. Immunology. 2018; 154(2):186-195. PMC: 5980179. DOI: 10.1111/imm.12910. View

4.
Liu S, Lu L, Pan F, Yang C, Liang J, Liu J . Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer. Oncol Res. 2022; 29(1):25-31. PMC: 9110705. DOI: 10.3727/096504022X16427607626672. View

5.
Ogino S, Chan A, Fuchs C, Giovannucci E . Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2010; 60(3):397-411. PMC: 3040598. DOI: 10.1136/gut.2010.217182. View